Feedback / Questions
tibulizumab (ZB-106) - Zura Bio
https://www.businesswire.com/news/home/20250325942559/en/Zura-Bio-Reports-Full-Year-2024-Financial-Results-and-Recent-Corporate-Updates
Mar 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next